Your browser doesn't support javascript.
loading
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
Lambertini, Matteo; Campbell, Christine; Gelber, Richard D; Viale, Giuseppe; McCullough, Ann; Hilbers, Florentine; Korde, Larissa A; Werner, Olena; Chumsri, Saranya; Jackisch, Christian; Wolff, Antonio C; Vaz-Luis, Ines; Ferreira, Arlindo R; Prat, Aleix; Moreno-Aspitia, Alvaro; Piccart, Martine; Loi, Sherene; de Azambuja, Evandro.
Affiliation
  • Lambertini M; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. matteo.lambertini@unige.it.
  • Campbell C; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. matteo.lambertini@unige.it.
  • Gelber RD; Frontier Science, Kingussie, UK.
  • Viale G; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA.
  • McCullough A; IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy.
  • Hilbers F; Mayo Clinic, Phoenix, AZ, USA.
  • Korde LA; Breast International Group, Brussels, Belgium.
  • Werner O; National Cancer Institute, Bethesda, MD, USA.
  • Chumsri S; Novartis Pharma AG, Basel, Switzerland.
  • Jackisch C; Mayo Clinic, Jacksonville, FL, USA.
  • Wolff AC; Sana Klinikum Offenbach, Offenbach, Germany.
  • Vaz-Luis I; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Ferreira AR; Institut Gustave Roussy, Villejuif, France.
  • Prat A; Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Moreno-Aspitia A; Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Piccart M; Mayo Clinic, Jacksonville, FL, USA.
  • Loi S; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • de Azambuja E; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
Breast Cancer Res Treat ; 177(1): 103-114, 2019 Aug.
Article in En | MEDLINE | ID: mdl-31134488
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Progesterone / Receptor, ErbB-2 Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Progesterone / Receptor, ErbB-2 Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Year: 2019 Type: Article